1-3 of 3
Stefania Tringali
Close
Sort by
Journal Articles

Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study

Salvatore Leotta, Andrea Duminuco, Antonino Mulè, Stefania Tringali, Elisa Mauro, Calogero Vetro, Cinzia Maugeri, Marina Parisi, Bruno Garibaldi, Nicola Di Renzo, Claudia Romano, Domenico Pastore, Massimo Gentile, Ernesto Vigna, Carmine Selleri, Giuseppe Milone, Uros Markovic
Journal: Blood
Blood (2022) 140 (Supplement 1): 11854–11855.
https://doi.org/10.1182/blood-2022-166546
Published: 2022
Journal Articles

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Desamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Enrica Antonia Martino, MD, Vittorio Del Fabro, MD, Giuseppe Sapienza, MD, Valeria Calafiore, Bruno Garibaldi, Salvatore Innorcia, Marina Parisi, MD, Emilia Cotzia, Ugo Consoli, MD, Massimo Poidomani, Cinzia Maugeri, Donato Mannina, MD, Vanessa Innao, MD, Maurizio Musso, Clotilde Cangialosi, MD, Stefania Tringali, Melania Carlisi, MD, Giuseppe Salvatore Longo, Alessandra Romano, MDPhD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5636.
https://doi.org/10.1182/blood-2018-99-116452
Published: 2018
Journal Articles

Interventional Strategies to Contain Colonization and Infections Caused By Carbapenemase Producing Klebsiella Pneumonia in Haematological Malignancies

Alessandra Malato, MD PhD, Francesco Acquaviva, Rosaria Felice, MD, Silvana Magrin, MD, Maria Grazia Donà, Rosanna Scimè, MD, Stefania Tringali, MD, Baldi maria Teresa, MD, Francesco Fabbiano, MD
Journal: Blood
Blood (2014) 124 (21): 2647.
https://doi.org/10.1182/blood.V124.21.2647.2647
Published: 2014